Complicated Skin and Skin Structure Infections

计划入组 1,000 人 · 首次发布于 2008 年 2 月 21 日

Avelox in Complicated Skin and Skin Structure Infections

计划入组 6,127 人 · 首次发布于 2009 年 10 月 20 日

A Study for Patients With Complicated Skin and Skin Structure Infections

计划入组 294 人 · 首次发布于 2007 年 8 月 10 日

Delafloxacin(Baxdela, Quofenix)

C₁₈H₁₂ClF₃N₄O₄

Equus caballus skin

Canis lupus familiaris skin

Integrative Skin Science and Research

CHARISMA SKIN

United States

UNC Dermatology and Skin Cancer Center

United States

Recce Pharmaceuticals' Phase II Trial of R327G for ABSSSI Reaches Halfway Enrollment

Recce Pharmaceuticals Completes Patient Dosing in Phase II Trial for Topical Gel Targeting Skin Infections

Recce Pharmaceuticals' R327G Shows 93% Efficacy in Phase II Trial for Bacterial Skin Infections